Home > National Drug Code (NDC) > Treatment Set TS351004

Treatment Set TS351004 - 49288-0946-3 - (Treatment Set TS351004)

Alphabetical Index


Drug Information of Treatment Set TS351004

Product NDC: 49288-0946
Proprietary Name: Treatment Set TS351004
Non Proprietary Name: Treatment Set TS351004
Active Ingredient(s): .002; .0004; .001; .001; .002; 80; .01; .01; .0004; 160    g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL; [BAU]/mL & nbsp;   Treatment Set TS351004
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS351004

Product NDC: 49288-0946
Labeler Name: Antigen Laboratories, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS351004

Package NDC: 49288-0946-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0946-3)

NDC Information of Treatment Set TS351004

NDC Code 49288-0946-3
Proprietary Name Treatment Set TS351004
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0946-3)
Product NDC 49288-0946
Product Type Name NON-STANDARDIZED ALLERGENIC
Non Proprietary Name Treatment Set TS351004
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ALTERNARIA ALTERNATA; AVENA SATIVA POLLEN; CARYA ALBA POLLEN; CARYA ILLINOINENSIS POLLEN; COCHLIOBOLUS SATIVUS; CYNODON DACTYLON POLLEN; FUSARIUM OXYSPORUM; JUNIPERUS VIRGINIANA POLLEN; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN
Strength Number .002; .0004; .001; .001; .002; 80; .01; .01; .0004; 160
Strength Unit g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL; [BAU]/mL
Pharmaceutical Classes Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS351004


General Information